FibroGen ~ James Schoeneck
FibroGen (NASDAQ: FGEN) $3.19b James Schoeneck appt interim CEO continues on Board
Base salary $1,600,000; Equity granted 97,100 shares, 57,300 RSU
FibroGen (NASDAQ: FGEN) $3.19b James Schoeneck appt interim CEO continues on Board
Base salary $1,600,000; Equity granted 97,100 shares, 57,300 RSU
No posts